Home Biosimilar Antibodies Immunology & Inflammation Complement System antibody Lendalizumab (Anti-Complement C5) For research use only.
Not for use in humans.

Lendalizumab (Anti-Complement C5)

Synonyms: ALXN1007, Olendalizumab

Lendalizumab (Anti-Complement C5) is a proprietary antibody that targets the complement protein C5a with potential immunomodulating and anti-inflammatory activities. MW : 146.02 KD.

Lendalizumab (Anti-Complement C5)

Purity & Quality Control

Choose Selective Complement System Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Lendalizumab (Anti-Complement C5) is a proprietary antibody that targets the complement protein C5a with potential immunomodulating and anti-inflammatory activities. MW : 146.02 KD.

Product Details

CAS No. 2210314-30-8
Molecular Weight 146.02
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lendalizumab (Anti-Complement C5) | Lendalizumab (Anti-Complement C5) supplier | purchase Lendalizumab (Anti-Complement C5) | Lendalizumab (Anti-Complement C5) cost | Lendalizumab (Anti-Complement C5) manufacturer | order Lendalizumab (Anti-Complement C5) | Lendalizumab (Anti-Complement C5) distributor